TLR4 agonists as vaccine adjuvants: achemist's perspective

被引：13
作者：
Johnson, David A. [1 ]
机构：
[1] GlaxoSmithKline Vaccines, Hamilton, MT 59840 USA
来源：
EXPERT REVIEW OF VACCINES | 2013年 / 12卷 / 07期
关键词：
AGP; aminoalkyl glucosaminide phosphate; lipid A mimetic; TLR4; agonist; TRIF selectivity; vaccine adjuvant; MONOPHOSPHORYL-LIPID-A; PATHWAYS;
D O I：
10.1586/14760584.2013.811189
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：711 / 713
页数：3
相关论文
共 50 条
  • [21] TLR4 Ligands Augment Antigen-Specific CD8+ T Lymphocyte Responses Elicited by a Viral Vaccine Vector
    Rhee, Elizabeth G.
    Kelley, R. Phelps
    Agarwal, Isha
    Lynch, Diana M.
    La Porte, Annalena
    Simmons, Nathaniel L.
    Clark, Sarah L.
    Barouch, Dan H.
    JOURNAL OF VIROLOGY, 2010, 84 (19) : 10413 - 10419
  • [22] Recognition of lipopolysaccharide pattern by TLR4 complexes
    Park, Beom Seok
    Lee, Jie-Oh
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2013, 45 : e66 - e66
  • [23] Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists
    Morin, Matthew D.
    Wang, Ying
    Jones, Brian T.
    Su, Lijing
    Surakattula, Murali M. R. P.
    Berger, Michael
    Huang, Hua
    Beutler, Elliot K.
    Zhang, Hong
    Beutler, Bruce
    Boger, Dale L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (10) : 4812 - 4830
  • [24] Differential outcome of TRIF-mediated signaling in TLR4 and TLR3 induced DC maturation
    Hu, Wei
    Jain, Aakanksha
    Gao, Yajing
    Dozmorov, Igor M.
    Mandraju, Rajakumar
    Wakeland, Edward K.
    Pasare, Chandrashekhar
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (45) : 13994 - 13999
  • [25] A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7
    Fox, Christopher B.
    Sivananthan, Sandra J.
    Duthie, Malcolm S.
    Vergara, Julie
    Guderian, Jeffrey A.
    Moon, Elliot
    Coblentz, David
    Reed, Steven G.
    Carter, Darrick
    JOURNAL OF NANOBIOTECHNOLOGY, 2014, 12
  • [26] A structure-function approach to optimizing TLR4 ligands for human vaccines
    Carter, Darrick
    Fox, Christopher B.
    Day, Tracey A.
    Guderian, Jeffrey A.
    Liang, Hong
    Rolf, Tom
    Vergara, Julie
    Sagawa, Zachary K.
    Ireton, Greg
    Orr, Mark T.
    Desbien, Anthony
    Duthie, Malcolm S.
    Coler, Rhea N.
    Reed, Steven G.
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2016, 5
  • [27] The 'Ethereal' nature of TLR4 agonism and antagonism in the AGP class of lipid A mimetics
    Bazin, Helene G.
    Murray, Tim J.
    Bowen, William S.
    Mozaffarian, Afsaneh
    Fling, Steven P.
    Bess, Laura S.
    Livesay, Mark T.
    Arnold, Jeffrey S.
    Johnson, Craig L.
    Ryter, Kendal T.
    Cluff, Christopher W.
    Evans, Jay T.
    Johnson, David A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (20) : 5350 - 5354
  • [28] Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy
    Kim, Hyunjoon
    Niu, Lin
    Larson, Peter
    Kucaba, Tamara A.
    Murphy, Katherine A.
    James, Britnie R.
    Ferguson, David M.
    Griffith, Thomas S.
    Panyam, Jayanth
    BIOMATERIALS, 2018, 164 : 38 - 53
  • [29] In vitro evaluation of TLR4 agonist activity: Formulation effects
    Misquith, Ayesha
    Fung, H. W. Millie
    Dowling, Quinton M.
    Guderian, Jeffrey A.
    Vedvick, Thomas S.
    Fox, Christopher B.
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2014, 113 : 312 - 319
  • [30] On vaccine's adjuvants and autoimmunity: Current evidence and future perspectives
    Pellegrino, Paolo
    Clementi, Emilio
    Radice, Sonia
    AUTOIMMUNITY REVIEWS, 2015, 14 (10) : 880 - 888
12345